Chatzistamatiou, Kimon

Dr Kimon Chatzistamatiou is an assistant Professor of Obstetrics and Gynaecology in the 1^st Department of Obstetrics and Gynecology at the Aristotle University of Thessaloniki, Greece. He received his MD (2002) and PhD (2017) from the Medical School of the Aristotle University of Thessaloniki. He is board-certified in Obstetrics and Gynecology (2013), certified in colposcopy and cervical pathology (2014), and has overseen the lower genital tract clinic at “Papageorgiou” General Hospital in Thessaloniki, Greece, since 2018. He currently is a clinical and research Fellow in Gynaecological Oncology.

For his doctoral thesis, graded “excellent with distinction”, he explored the utility of HPVE7 oncoprotein detection for the triage of women, tested high-risk-HPV positive, to colposcopy, and has been the recipient of the University’s award for high academic standards and excellence.

Since 2011, he has participated in four nationwide multicenter studies in Greece:

• The “LYSISTRATA” study, (HPV epidemiology, HPV vaccination acceptance).
• The “HERMES” study, (diagnostic accuracy of HPV primary cervical cancer screening).
• The “PIPAVIR” study, funded by the EUFP4, (HPV-DNA testing and HPVE7-oncoprotein detection in cervical cancer screening).
• The “GRECOSELF” study, (HPV-DNA primary screening with self-sampling).

Currently he investigates, as the Principal Investigator, the utility of P16/Ki-67 dual immunocytochemistry testing for the surveillance of women with CIN2 (CIN2DIN study).

He is a Board member of the Hellenic HPV Society, a Board Member of the International Papillomavirus Society (IPVS), co-Chair of the IPVS Education Committee, and a member of the IPVS Policy Committee. Also, he is a member of the European Society of Gynaecological Oncology (ESGO) prevention committee, and he has been selected as a member of the expert pool of European Commission Initiative on Cervical Cancer (EC-CvC).